Please provide your email address to receive an email when new articles are posted on . SEATTLE —There was no significant difference in cognitive outcomes for patients with retinopathy of prematurity ...

A UB researcher who is a leading expert on retinopathy of prematurity (ROP) has published a study that could change the standard of care for the condition. ROP occurs in low birthweight premature ...

SAN FRANCISCO — Retinopathy of prematurity seems to respond equally to either an injection with aflibercept or laser photocoagulation when infants who were treated reached age 2 years, according to ...

Data suggests fentanyl used during laser therapy for retinopathy of prematurity is a safe and effective alternative to anesthesia, according to a poster presentation at the American Association for ...

Please provide your email address to receive an email when new articles are posted on . A study published in 2023 that analyzed more than 23 million births found that the proportion of premature ...

A 0.4 mg dose of aflibercept in infancy to treat retinopathy of prematurity (ROP) shows sustained efficacy and safety at 3 years of age, according to research presented at EURETINA 2024. No ...